Counseling of the PD predisposition risk in nonmanifesting GBA1 carriers or the prognostic trajectory in PD patients with a recently identified GBA1 variant has been limited for many years by significant uncertainty over the pathogenicity associated with specific variants. Here, GBA1 is linked to Parkinson disease.